Cox MJ, Ege MJ, von Mutius E. The Fungal Kingdom: Opportunities and Challenges for Medical Mycology. Cold Spring Harbor Perspectives in Medicine. 2020.
[2]
Maschmeyer G, Helweg-Larsen J, Pagano L, et al. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients. J Antimicrob Chemother. 2016;71(9):2405-2413.
[3]
Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487-2498.
[4]
World Health Organization. Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children. WHO; 2014.
[5]
Kovacs JA, Masur H. Prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med. 2009;360(21):2156-2165.